Navigation Links
Novel Anticoagulants Will Garner More Than Three-Quarters of the Atrial Fibrillation Drug Market in 2017
Date:12/4/2008

WALTHAM, Mass., Dec. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that novel anticoagulants that include emerging drugs from Boehringer Ingelheim, Bayer/Johnson & Johnson and Bristol-Myers Squibb/Pfizer, will garner more than three-quarters of the atrial fibrillation drug market by 2017.

The new Pharmacor report entitled Atrial Fibrillation finds that the most promising emerging oral anticoagulants are Boehringer Ingelheim's Pradaxa/Rendix, Bayer/Johnson & Johnson's Xarelto and Bristol-Myers Squibb/Pfizer's apixaban, which will each garner peak-year blockbuster sales of more than $1 billion in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. New anticoagulants, which will largely displace the use of the vitamin K antagonist drug class, will garner 76 percent of the atrial fibrillation market in 2017, owing to the strong potential each agent has in preventing stroke.

The report finds that the emergence and success of novel oral anticoagulants, combined with the launch and extensive uptake of Sanofi-Aventis's antiarrhythmic drug Multaq, will drive 15 percent annual market growth from 2007 to 2012. Market growth from 2012 to 2017 will then increase to a robust 27 percent annually, driving overall sales of atrial fibrillation therapies to $5.4 billion in 2017, compared to just over $800 million in 2007.

"Multaq, with its favorable efficacy and safety profile and its ability to reduce hospitalization and prevent stroke, will launch in 2009 and its arrival will enjoy wide acceptance by physicians," said Samira Benyoucef, Ph.D., analyst at Decision Resources. "Additionally, the introduction of more convenient and safe novel anticoagulants that offer advantages over existing agents will fuel significant expansion of the atrial fibrillation market over the next decade."


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , ... August 31, 2015 , ... The dental implant ... according the American Academy of Implant Dentistry. (See Press Room ) More than ... require an implant procedure. With the increasing demand for dental implants, the National Association ...
(Date:8/31/2015)... Angeles, California (PRWEB) , ... August 31, 2015 ... ... pilot by host/actor/writer/director/ CSUN psychology professor Luciana Lagana (aka Dr. Luciana) received ... Awards, for Best Web Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana ...
(Date:8/31/2015)... ... August 31, 2015 , ... People with hostile personality traits ... for injury, potentially because they are more susceptible to the influence of television ... Health analysis discovered. , The research, published online in the International Journal ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... September by sharing the facts about the role of heredity in below-the-belt gynecologic ... mutations because of Angelina Jolie Pitt’s decisions to have both her breasts and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. Roll over ... barbershops are scrambling to meet it. , Reports published this year (Mintel data) announced ... But the data also reflects that men are getting more done at barbershops than ...
Breaking Medicine News(10 mins):Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3
... , THURSDAY, March 10 (HealthDay News) -- Most ... that surgeons should adjust for when they perform surgeries ... Previous studies have found that cerebral palsy patients ... hips, but this is the first study to find ...
... most children with severe cerebral palsy have starkly asymmetric ... surgeries of the pelvis, spine and surrounding structures are ... be published online on March 10 in the ... patients with cerebral palsy have reported asymmetry above the ...
... HealthDay Reporter , WEDNESDAY, March 9 (HealthDay News) -- ... get injections of a new insulin drug just three times a ... be confirmed in another phase of research, and it,s not clear ... this use. But those caveats aside, the study raises the ...
... Serena Gordon HealthDay Reporter , WEDNESDAY, March 9 ... blood pressure may also help protect the kidneys of people ... caveat. In a new study, an international team ... name Benicar, could increase the time before any kidney problems ...
... team of researchers at Brigham and Womens Hospital (BWH) ... adult smokers have abnormal lung densities present on chest ... which is associated with substantial reductions in lung volumes. ... these lung densities were inversely not associated with emphysema. ...
... Neurological Institute has received a $10.1 million donation, the ... of the biggest ever given to any Arizona hospital. ... Rochelle to St. Joseph,s Barrow Neurological Institute in Phoenix ... for psychiatric and motor disorders by using novel treatments ...
Cached Medicine News:Health News:Hopkins Children's study finds some patients with cerebral palsy have asymmetric pelvic bones 2Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2Health News:Blood Pressure Drug Delays Kidney Disease in Diabetics 2Health News:Blood Pressure Drug Delays Kidney Disease in Diabetics 3Health News:Researchers find smoking may increase risk for lung disease 2Health News:Deep brain stimulation research expands at Barrow 2Health News:Deep brain stimulation research expands at Barrow 3
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), ... biomedical innovations in ophthalmology and cancer diagnostics, today ... (TASE: MCTC), has identified several new genetic markers ... jawbone in patients treated with bisphosphonate drugs and ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
... Plus, Higher then Expected MCI Prevalence Shows Urgent ... Two studies related to,experimental Alzheimer,s therapies reported ... Conference on Alzheimer,s,Disease (ICAD 2008) in Chicago., ... AL-108, targeted early,abnormal brain changes in a protein ...
... July 28 Cardium Therapeutics,(Amex: CXM ) ... as Chief,Medical Officer to lead the Company,s late-stage ... the MATRIX Phase 2b,clinical study that is evaluating ... ulcers, and the AWARE Phase 3 clinical study ...
Cached Medicine Technology:Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 2Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 3Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 4Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 5Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 6Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 2Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 3Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 4Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 5
... with Tim™ (Total imaging matrix) technology ... and highest resolution at 3T. With ... advanced applications can now be translated ... with Tim is an excellent dual-purpose ...
... Billing Assistant (MBA) is a ... and practice management software package. ... SQL Server technology and is ... and account receivable management, MBA ...
... a practice management system. DAQbilling files all ... Your patient statements can also be printed and ... traditional software and billing services into one software ... anywhere - multiples offices or home. ...
... G-3 goniofundus lens incorporate 3 mirrors angled at ... ideal for anterior chamber as well as central ... retinal viewing mirrors are accurately angled and spaced ... fundus. The central portion of the lens ...
Medicine Products: